{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:51Z","timestamp":1792788291624,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eururo.2023.04.018","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:41:08Z","timestamp":1684374068000},"page":"257-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Management of Lymph Node\u2013positive Penile Cancer: A Systematic Review"],"prefix":"10.1016","volume":"85","author":[{"given":"Ashwin","family":"Sachdeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Zapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herney Andres","family":"Garcia-Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithun","family":"Kailavasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Antunes-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Manzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack David","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Protzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bryan Rumble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"S\u00e1nchez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel S.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie S.","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis A.","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Sangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios I.","family":"Sakalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.04.018_b0005","series-title":"EAU guidelines on penile cancer","author":"Hakenberg","year":"2020"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2023.04.018_b0010","doi-asserted-by":"crossref","first-page":"vi115","DOI":"10.1093\/annonc\/mdt286","article-title":"Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Van Poppel","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0015","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2023.04.018_b0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00345-020-03221-z","article-title":"Final results of the PraVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure","volume":"39","author":"Schmid","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.urology.2017.11.007","article-title":"Video endoscopic inguinal lymphadenectomy vs open inguinal lymphadenectomy for carcinoma penis: expanding role and comparison of outcomes","volume":"113","author":"Yadav","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","article-title":"Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0040","doi-asserted-by":"crossref","first-page":"641.e9","DOI":"10.1016\/j.urolonc.2020.03.026","article-title":"Adjuvant radiation compares favorably to chemotherapy in patients with carcinoma penis and nodal positivity restricted to groin","volume":"38","author":"Jaipuria","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0045","doi-asserted-by":"crossref","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","article-title":"Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"35","author":"Tang","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0050","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.21037\/tau-20-1044","article-title":"Adding radiotherapy based on chemotherapy can improve cancer-specific survival in N3 penile cancer: a SEER-based study","volume":"9","author":"Chen","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.23736\/S0393-2249.19.03387-3","article-title":"Is there any benefit in adding postoperative adjuvant concurrent radiotherapy and chemotherapy for penile cancer with regional lymph node metastasis?","volume":"72","author":"Choo","year":"2020","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.eururo.2023.04.018_b0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-020-03179-y","article-title":"Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study","volume":"39","author":"Li","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","article-title":"Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: results of a multicenter analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","article-title":"A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings","volume":"14","author":"Nicolai","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0075","doi-asserted-by":"crossref","first-page":"531.e7","DOI":"10.1016\/j.urolonc.2019.04.003","article-title":"Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: a retrospective multicenter study","volume":"37","author":"Necchi","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0080","doi-asserted-by":"crossref","unstructured":"Liu WK, Patel R, Crawford R, et al. Longitudinal cohort analysis of patients with metastatic penile cancer treated in a large quaternary academic centre. J Clin Urol. In press. https:\/\/doi.org\/10.1177\/20514158211025913.","DOI":"10.1177\/20514158211025913"},{"key":"10.1016\/j.eururo.2023.04.018_b0085","doi-asserted-by":"crossref","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00432-016-2292-3","article-title":"Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study","volume":"143","author":"Li","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00345-015-1593-5","article-title":"Extent of pelvic lymph node dissection in penile cancer may impact survival","volume":"34","author":"Zargar-Shoshtari","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00345-003-0383-7","article-title":"Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan","volume":"22","author":"Chen","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0360-3016(92)91062-R","article-title":"Iridium-192 interstitial therapy for squamous cell carcinoma of the penis","volume":"24","author":"Delannes","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2023.04.018_b0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1023\/A:1007123530694","article-title":"The treatment of penile carcinoma: experience in 64 cases","volume":"31","author":"Demkow","year":"1999","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2023.04.018_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","article-title":"Contemporary management of regional nodes in penile cancer\u2014improvement of survival?","volume":"191","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0125","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","article-title":"Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals","volume":"186","author":"Franks","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.10.059","article-title":"Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management","volume":"185","author":"Graafland","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.euf.2018.10.007","article-title":"Primary penile cancer: the role of adjuvant radiation therapy in the management of extranodal extension in lymph nodes","volume":"5","author":"Johnstone","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2023.04.018_b0140","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1464-410X.1994.tb09199.x","article-title":"Role of radiation therapy in the treatment of carcinoma of the penis","volume":"74","author":"Ravi","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0145","doi-asserted-by":"crossref","first-page":"92.e11","DOI":"10.1016\/j.urolonc.2017.11.005","article-title":"Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database","volume":"36","author":"Winters","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0150","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","article-title":"DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation","volume":"54","author":"Maibom","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clgc.2014.03.009","article-title":"Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma","volume":"12","author":"Pond","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/end.2017.0455","article-title":"Comparative study of video endoscopic inguinal lymphadenectomy through a hypogastric vs leg subcutaneous approach for penile cancer","volume":"32","author":"Yuan","year":"2018","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2023.04.018_b0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0180","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0185","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0190","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12885-019-5847-2","article-title":"Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0200","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00432-014-1720-5","article-title":"Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China","volume":"140","author":"Zou","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0210","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0215","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0220","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","article-title":"Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0230","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.eururo.2023.04.018_b0235","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.urolonc.2013.10.007","article-title":"Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy","volume":"32","author":"Pond","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0240","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3889\/oamjms.2019.201","article-title":"Evaluation of paclitaxel, ifosfamide, and cisplatin (TIP) regimen on penile cancer in Adam Malik Medan: a single center 2 years of experience","volume":"7","author":"Sitompul","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.eururo.2023.04.018_b0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1081\/CNV-120016402","article-title":"A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893)","volume":"21","author":"Skeel","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.eururo.2023.04.018_b0250","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","article-title":"Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes","volume":"85","author":"Wang","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0255","doi-asserted-by":"crossref","first-page":"32212","DOI":"10.18632\/oncotarget.4802","article-title":"Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2023.04.018_b0260","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0265","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","article-title":"The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection","volume":"31","author":"Liu","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0270","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ssu.2980060411","article-title":"Bilateral ilioinguinal lymph node dissection in the management of cancer of the penis","volume":"6","author":"Pow-Sang","year":"1990","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0280","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/JU.0000000000001322","article-title":"Lymph node mapping in patients with penile cancer undergoing pelvic lymph node dissection","volume":"205","author":"Yao","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0285","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.juro.2015.03.090","article-title":"Establishing criteria for bilateral pelvic lymph node dissection in the management of penile cancer: lessons learned from an international multicenter collaboration","volume":"194","author":"Zargar-Shoshtari","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0290","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0295","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-5347(17)36126-8","article-title":"Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes","volume":"149","author":"Horenblas","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0300","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000475360","article-title":"Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1\u20132A carcinoma of the penis","volume":"26","author":"Kulkarni","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0305","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.juro.2010.06.016","article-title":"Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma","volume":"184","author":"Graafland","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0310","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","article-title":"Treatment trends and outcomes for patients with lymph node-positive cancer of the penis","volume":"4","author":"Joshi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0315","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.juro.2013.06.016","article-title":"Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes","volume":"190","author":"Koifman","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0320","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.urolonc.2013.11.008","article-title":"Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density","volume":"32","author":"Li","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0325","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-5347(01)65471-5","article-title":"Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy","volume":"156","author":"Lopes","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0330","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11255-019-02084-7","article-title":"More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer","volume":"51","author":"Mao","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2023.04.018_b0335","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jso.20980","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience","volume":"97","author":"Ornellas","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0340","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11701-020-01189-x","article-title":"Comparative study of perioperative and survival outcomes after video endoscopic inguinal lymphadenectomy (VEIL) and open inguinal lymph node dissection (O-ILND) in the management of inguinal lymph nodes in carcinoma of the penis","volume":"15","author":"Thyavihally","year":"2021","journal-title":"J Robot Surg"},{"key":"10.1016\/j.eururo.2023.04.018_b0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.urology.2021.07.011","article-title":"Real world data of penile cancer treatment at a high-volume center in South America: insights and survival trends","volume":"156","author":"Chavarriaga","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0350","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.juro.2010.02.025","article-title":"Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy","volume":"183","author":"Marconnet","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0355","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","article-title":"Oncologic outcomes of penile cancer treatment at a UK supraregional center","volume":"85","author":"Veeratterapillay","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0360","first-page":"204","article-title":"The risks of lymph node metastasis and the prognostic factors in carcinoma of the penis: analysis of 50 patients treated with bilateral ilionguinal lymphadenectomy","volume":"84","author":"Leewansangtong","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.eururo.2023.04.018_b0365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bjmsu.2011.12.009","article-title":"Inguinal lymphadenectomy for squamous cell cancer of the penis\u2014experience of a UK supra-regional network","volume":"5","author":"Martin","year":"2012","journal-title":"Br J Med Surg Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0370","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","article-title":"Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis","volume":"72","author":"Ravi","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0375","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bju.13686","article-title":"Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma","volume":"119","author":"Reddy","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0380","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/JU.0000000000001790","article-title":"Patterns of recurrence following inguinal lymph node dissection for penile cancer: optimizing surveillance strategies","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.urology.2021.02.019","article-title":"Contemporary incidence and predictors of occult inguinal lymph node metastases in men with clinically node-negative (cN0) penile cancer","volume":"153","author":"Unadkat","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0390","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.juro.2017.06.076","article-title":"Delay to inguinal lymph node dissection greater than 3 months predicts poorer recurrence-free survival for patients with penile cancer","volume":"198","author":"Chipollini","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0395","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0022-5347(01)66863-0","article-title":"Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion","volume":"154","author":"McDougal","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0400","doi-asserted-by":"crossref","first-page":"578.e11","DOI":"10.1016\/j.urolonc.2019.05.024","article-title":"Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: effect on survival and complication rates","volume":"37","author":"Mistretta","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0405","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0410","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1002\/cncr.25091","article-title":"Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program","volume":"116","author":"Johnson","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2023.04.018_b0415","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000354401","article-title":"Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma","volume":"92","author":"Zhu","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bju.14883","article-title":"Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection","volume":"125","author":"Chipollini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0425","doi-asserted-by":"crossref","first-page":"471.e19","DOI":"10.1016\/j.urolonc.2018.07.010","article-title":"Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer","volume":"36","author":"Soodana-Prakash","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0430","doi-asserted-by":"crossref","first-page":"e13154","DOI":"10.1111\/and.13154","article-title":"The appropriate number of negative lymph nodes dissection for nonmetastatic penile cancer","volume":"51","author":"Wei","year":"2019","journal-title":"Andrologia"},{"key":"10.1016\/j.eururo.2023.04.018_b0435","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.juro.2009.08.029","article-title":"Association between lymph node density and disease specific survival in patients with penile cancer","volume":"182","author":"Svatek","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0440","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0022-5347(05)65169-5","article-title":"Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience","volume":"167","author":"Bevan-Thomas","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0445","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.eururo.2003.12.003","article-title":"Morbidity of inguinal lymphadenectomy for invasive penile carcinoma","volume":"45","author":"Bouchot","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0450","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.ju.0000131453.52463.8f","article-title":"Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series","volume":"172","author":"Nelson","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0455","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2013.02.037","article-title":"Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis","volume":"64","author":"Stuiver","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0460","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.juro.2010.03.140","article-title":"Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome","volume":"184","author":"Yao","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0465","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/S1677-5538.IBJU.2014.0304","article-title":"Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer","volume":"41","author":"Tsaur","year":"2015","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0470","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00345-014-1471-6","article-title":"Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection","volume":"33","author":"Sharma","year":"2015","journal-title":"World J Urol"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2023.04.018_b0475","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.21037\/tau.2019.01.05","article-title":"Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure-a retrospective single centre study","volume":"8","author":"Alnajjar","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0480","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1590\/s1677-5538.ibju.2021.0169","article-title":"The role of primary inguinal surgical debulking for locally advanced penile cancer followed by reconstruction with myocutaneous flap","volume":"47","author":"Koifman","year":"2021","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0485","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00345-011-0706-z","article-title":"Tensor fascia lata flap reconstruction following groin dissection: is it worthwhile?","volume":"29","author":"Nirmal","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0490","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1464-410X.1993.tb16304.x","article-title":"Morbidity following groin dissection for penile carcinoma","volume":"72","author":"Ravi","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0495","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/s41598-022-06494-z","article-title":"Comparison of different surgical methods and strategies for inguinal lymph node dissection in patients with penile cancer","volume":"12","author":"Shao","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2023.04.018_b0500","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bju.13660","article-title":"Prospective study comparing video-endoscopic radical inguinal lymph node dissection (VEILND) with open radical ILND (OILND) for penile cancer over an 8-year period","volume":"119","author":"Kumar","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0505","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.euros.2021.10.004","article-title":"Saphenous-sparing ascending video endoscopic inguinal lymph node dissection using a leg approach: surgical technique and perioperative and pathological outcomes","volume":"35","author":"Fankhauser","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2023.04.018_b0510","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.juro.2017.12.061","article-title":"Comparing outcomes of robotic and open inguinal lymph node dissection in patients with carcinoma of the penis","volume":"199","author":"Singh","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0515","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/end.2012.0489","article-title":"Endoscopic inguinofemoral lymphadenectomy\u2014extended follow-up","volume":"27","author":"Schwentner","year":"2013","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2023.04.018_b0520","first-page":"4623","article-title":"Comparison of efficiency of video endoscopy and open inguinal lymph node dissection","volume":"37","author":"Wang","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2023.04.018_b0525","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2017.04.022","article-title":"Minimally invasive inguinal lymphadenectomy in the management of penile carcinoma","volume":"106","author":"Russell","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.04.018_b0530","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1464-410X.2012.11729.x","article-title":"Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma","volume":"111","author":"Matin","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0535","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12894-019-0571-4","article-title":"Robot-assisted laparoscopic antegrade versus open inguinal lymphadenectomy: a retrospective controlled study","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0540","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.clgc.2020.02.007","article-title":"Definitive chemoradiotherapy for locally advanced, lymph-node positive, nonmetastatic penile squamous cell carcinoma","volume":"18","author":"McComas","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2023.04.018_b0545","doi-asserted-by":"crossref","first-page":"VI291","DOI":"10.1093\/annonc\/mdw373.66","article-title":"Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis","volume":"27","author":"Necchi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0550","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clon.2021.10.005","article-title":"Impact of adjuvant treatment in pN3 penile cancer","volume":"34","author":"Khurud","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.eururo.2023.04.018_b0555","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","article-title":"The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer","volume":"36","author":"Yuan","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0560","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bju.15054","article-title":"Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma","volume":"125","author":"Bandini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.04.018_b0565","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive penile cancer: a systematic review by the European Association of Urology Penile Cancer Guidelines Panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.04.018_b0570","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile Advanced Cancer Trial (InPACT): rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur Urol Focus"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823027793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823027793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:14:28Z","timestamp":1759583668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823027793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0302283823027793"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.04.018","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Lymph Node\u2013positive Penile Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}